Panel Discussion: Clarifying Key National Regulatory Requirements to Begin Clinical Trials

Time: 1:45 pm
day: Clinical Operations Discussion Day


  • Amassing an inventory of key process requirements for successful clinical trial applications across a select number of countries popular for rare disease trials
  • A high-level viewpoint of different timescales and key filing differences for these countries
  • How to navigate different requirements across multiple domestic internal review boards to avoid significant delays.